Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Receivables (2020 - 2026)

Analysis

Starling Oncology (STLN) Receivables (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn 12.28 Bn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn 2.91 Bn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn 687.30 Mn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 3.03 Bn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn 2.80 Bn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn 676.80 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 188.63 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn 723.91 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn 299.82 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn 66.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.71 Mn
Mar 31, 2026 59.45 Mn
Dec 31, 2025 58.98 Mn
Sep 30, 2025 59.98 Mn
Jun 30, 2025 55.94 Mn
Mar 31, 2025 49.67 Mn
Dec 31, 2024 48.32 Mn
Sep 30, 2024 54.86 Mn
Jun 30, 2024 54.37 Mn
Mar 31, 2024 59.13 Mn
Dec 31, 2023 42.45 Mn
Sep 30, 2023 48.91 Mn
Jun 30, 2023 46.89 Mn
Mar 31, 2023 46.38 Mn
Dec 31, 2022 39.87 Mn
Sep 30, 2022 35.38 Mn
Jun 30, 2022 29.37 Mn
Mar 31, 2022 25.79 Mn
Dec 31, 2021 20.48 Mn
Dec 31, 2020 17.26 Mn